Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
3. Allegro hunts lung cancer’s "canary in the coal mine"
Allegro Diagnostics is in clinical trials for its flagship diagnostic assay, designed to detect the early stages of lung cancer, the deadliest cancer on the planet.
2. IOM was right about elimination of 510(k), NEJM says
The New England Journal of Medicine backed the Institute of Medicine’s controversial report on the FDA’s medical device fast-track, calling for the outright abolition of the 510(k) program.
1. Zimmer and Stryker poaching spat gets messy
Lawyers in a lawsuit filed by Stryker Corp. (NYSE:SYK) accusing Zimmer Holdings Inc. (NYSE:ZMH) of building its spine business on the back of Stryker’s scuffled over document disclosure deadlines, accusing each other of being "ludicrous," "frivolous," "premature" and guilty of "blatant gamesmanship." And that’s just what they put down on paper.